Hosted on MSN1h
Novo Nordisk Jumps After Ozempic Decidedly Beats. But 'Periodic Supply Constraints' Expected.Novo Nordisk stock jumped early Wednesday after the weight-loss drugs leader reported adjusted earnings of 88 cents per share ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback